{"id":"W2588397197","doi":"10.1093/annonc/mdw370.55","title":"A phase 1 study evaluating the pharmacokinetics (PK) and safety of regorafenib (REG) in patients with advanced solid tumors with severe renal impairment (SRI)","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Pharmacokinetics; Renal function; Urology; Adverse effect; Creatinine; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Dosing; Internal medicine; Gastroenterology; Chemotherapy; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001208573,0.001146943,0.001965043,0.0003057737,0.0003986951,0.0007531777,0.0005281944,0.0007592085,0.002662342],"category_scores_gemma":[0.00128893,0.0004537106,0.001764683,0.0004053034,0.0008262497,0.0007956537,0.0002773257,0.003541978,0.0005767511],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008367845,"about_ca_system_score_gemma":0.002039015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000948835,"about_ca_topic_score_gemma":0.00198595,"domain_scores_codex":[0.9995766,0.0002091578,0.00001680075,0.00007904631,0.00003977649,0.00007857866],"domain_scores_gemma":[0.9990782,0.0001818014,0.0002014557,0.000106889,0.00006018747,0.0003715744],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7615748,0.04961621,0.0186129,0.0007290886,0.002274707,0.0003795995,0.0004274604,0.004727936,0.04553663,0.0004337268,0.004536109,0.1111508],"study_design_scores_gemma":[0.3244349,0.6330605,0.02713584,0.0000293062,0.0009168875,0.0008341027,0.0001074646,0.002171963,0.00617886,0.0003166081,0.004753007,0.00006057815],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958722,0.0008172994,0.0004335601,0.0002309711,0.00004660059,0.0007430186,0.0007727383,0.00006067809,0.001022854],"genre_scores_gemma":[0.9935818,0.0008157938,0.001156977,0.0005547665,0.0001082843,0.0007119098,0.001822067,0.00003030718,0.001218168],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002662342,"threshold_uncertainty_score":0.008906364,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05591337534715176,"score_gpt":0.4009282352519746,"score_spread":0.3450148599048228,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}